Literature DB >> 3153311

Variants of Alport's syndrome.

J P Grünfeld1, G Grateau, L H Noel, R Charbonneau, M C Gubler, C O Savage, C M Lockwood.   

Abstract

Variants of Alport's syndrome include mainly those associated with hereditary macrothrombocytopenia (and occasionally leukocyte inclusions) or with esophageal, tracheobronchial and genital leiomyomatosis. Within Alport's syndrome there appears to be no justification for differentiating those with nephritis and deafness from those with nephritis alone. However, in indirect immunofluorescence studies using the mouse monoclonal antibody, MCA-P1, which recognizes the glomerular basement membrane (GBM), reduced or absent binding was found in 20 of 42 cases of hereditary nephritis. Most of these showed typical ultrastructural GMB changes. These results suggest that there is probably a subset of patients characterized by typical GBM lesions and an absence, inaccessibility or abnormality of the GBM antigen recognized by MCA-P1.

Entities:  

Mesh:

Year:  1987        PMID: 3153311     DOI: 10.1007/bf00849247

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  14 in total

1.  Smooth-muscle tumours of the oesophagus.

Authors:  J B JOHNSTON; O T CLAGETT; J R McDONALD
Journal:  Thorax       Date:  1953-12       Impact factor: 9.139

2.  Hereditary thrombocytopenia, deafness, and renal disease.

Authors:  J D Eckstein; D J Filip; J C Watts
Journal:  Ann Intern Med       Date:  1975-05       Impact factor: 25.391

3.  Fechtner syndrome--a variant of Alport's syndrome with leukocyte inclusions and macrothrombocytopenia.

Authors:  L C Peterson; K V Rao; J T Crosson; J G White
Journal:  Blood       Date:  1985-02       Impact factor: 22.113

4.  Thrombocytopenia, macrothrombocytopathia, nephritis and deafness.

Authors:  J Bernheim; M Dechavanne; P A Bryon; M Lagarde; S Colon; N Pozet; J Traeger
Journal:  Am J Med       Date:  1976-07       Impact factor: 4.965

5.  Nephritogenic antigen determinants in epidermal and renal basement membranes of kindreds with Alport-type familial nephritis.

Authors:  C Kashtan; A J Fish; M Kleppel; K Yoshioka; A F Michael
Journal:  J Clin Invest       Date:  1986-10       Impact factor: 14.808

6.  Hereditary macrothrombocytopathia, nephritis and deafness.

Authors:  C J Epstein; M A Sahud; C F Piel; J R Goodman; M R Bernfield; J H Kushner; A R Ablin
Journal:  Am J Med       Date:  1972-03       Impact factor: 4.965

7.  The Goodpasture antigen in Alport's syndrome: studies with a monoclonal antibody.

Authors:  C O Savage; C D Pusey; M J Kershaw; S J Cashman; P Harrison; B Hartley; D R Turner; J S Cameron; D J Evans; C M Lockwood
Journal:  Kidney Int       Date:  1986-07       Impact factor: 10.612

8.  Alport's syndrome: experience at Hôpital Necker.

Authors:  R Habib; M C Gubler; N Hinglais; L H Noël; D Droz; M Levy; P Mahieu; J M Foidart; D Perrin; E Bois; J P Grünfeld
Journal:  Kidney Int Suppl       Date:  1982-05       Impact factor: 10.545

9.  Hereditary nephritis associated with May-Hegglin anomaly.

Authors:  F Brivet; R Girot; C Barbanel; C Gazengel; M Maier; J Crosnier
Journal:  Nephron       Date:  1981       Impact factor: 2.847

10.  Use of a monoclonal antibody in differential diagnosis of children with haematuria and hereditary nephritis.

Authors:  C O Savage; A Reed; M Kershaw; J Pincott; C D Pusey; M J Dillon; T M Barratt; C M Lockwood
Journal:  Lancet       Date:  1986-06-28       Impact factor: 79.321

View more
  3 in total

Review 1.  Alport's syndrome.

Authors:  F Flinter
Journal:  J Med Genet       Date:  1997-04       Impact factor: 6.318

2.  Type IV renal tubular acidosis associated with Alport's syndrome.

Authors:  R Tkácová; R Roland; A Böör; A Kovácová; I Lazúrová; I Tkác; T Hildebrand; P Sefara
Journal:  Postgrad Med J       Date:  1993-10       Impact factor: 2.401

3.  Alport's syndrome or hereditary nephritis?

Authors:  F A Flinter; M Bobrow; C Chantler
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.